First Men in the Moon ipod Anastasia movie download
Two lawsuits filed by West Virginia families claim the antidepressant Paxil was responsible for their children’s birth defects.
The Food and Drug Administration (FDA) announced in December 2005 that it was requiring Glaxo to add warnings of birth defects to the drug’s prescribing information. This decision was fueled by two studies that showed that women who took Paxil during the first three months of pregnancy were about one and a half to two times as likely to have a baby with a heart defect than women who took other antidepressants or women in the general population.
The lawsuits claim that Glaxo knew that Paxil was associated with birth defects prior to the 2005 label change and that the heart birth defects that are present in their children wre the result of their mother’s Paxil use during pregnancy.
The women involved in the lawsuits claim that they took Paxil because Glaxo promoted the drug as a safe alternative to pregnant women. However, when their children were born, they suffered from congenital injuries and disorders and birth defects, as well as heart defects and developmental delays.
Also, a class action lawsuit has been settled that will reimburse health plans that paid for children and young adults who receive Paxil. While the drug is not approved for use in children, doctors often prescribe the drug when they see fit. While Paxil isn’t necessarily a defective drug, several studies have shown that Paxil and similar antidepressants cause suicides in teenagers.
If you or a member of your family were prescribed Paxil and suffered adverse side effects, you should contact an experienced defective drug attorney for professional insight.
